These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2156 related items for PubMed ID: 9234595

  • 1. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

  • 2. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C, Rowley JD, Nucifora G.
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [Abstract] [Full Text] [Related]

  • 3. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S, Lenny N, Sun W, Hiebert SW.
    Oncogene; 1996 Jul 18; 13(2):303-12. PubMed ID: 8710369
    [Abstract] [Full Text] [Related]

  • 4. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.
    Clin Cancer Res; 2005 Apr 15; 11(8):2974-80. PubMed ID: 15837750
    [Abstract] [Full Text] [Related]

  • 5. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C, Kim N, Hiebert S, Zhang DE, Tenen DG, Rowley JD, Nucifora G.
    Curr Top Microbiol Immunol; 1996 Apr 15; 211():243-52. PubMed ID: 8585955
    [Abstract] [Full Text] [Related]

  • 6. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL, Wiktor A, Rowley JD.
    Genes Chromosomes Cancer; 2004 Aug 15; 40(4):365-70. PubMed ID: 15188461
    [Abstract] [Full Text] [Related]

  • 7. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H, Tanabe K, Mizushima H, Hayashi Y, Mizutani S, Ishii E, Hongo T, Kikuchi A, Satake M.
    Br J Haematol; 2006 Nov 15; 135(3):336-47. PubMed ID: 16989659
    [Abstract] [Full Text] [Related]

  • 8. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
    Erickson PF, Robinson M, Owens G, Drabkin HA.
    Cancer Res; 1994 Apr 01; 54(7):1782-6. PubMed ID: 8137293
    [Abstract] [Full Text] [Related]

  • 9. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM, Coignet L, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM, Farahat N, Nucifora G.
    Genes Chromosomes Cancer; 2004 Feb 01; 39(2):110-8. PubMed ID: 14695990
    [Abstract] [Full Text] [Related]

  • 10. The 8;21 translocation in leukemogenesis.
    Peterson LF, Zhang DE.
    Oncogene; 2004 May 24; 23(24):4255-62. PubMed ID: 15156181
    [Abstract] [Full Text] [Related]

  • 11. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr 24; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 12. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD.
    Oncogene; 1999 Mar 04; 18(9):1701-10. PubMed ID: 10208431
    [Abstract] [Full Text] [Related]

  • 13. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
    Cuenco GM, Ren R.
    Oncogene; 2004 Jan 15; 23(2):569-79. PubMed ID: 14724585
    [Abstract] [Full Text] [Related]

  • 14. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D.
    Cancer; 2006 Apr 15; 106(8):1730-8. PubMed ID: 16532439
    [Abstract] [Full Text] [Related]

  • 15. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
    Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marín-Padilla M, Tenen DG, Speck NA, Zhang DE.
    Nat Genet; 1997 Mar 15; 15(3):303-6. PubMed ID: 9054947
    [Abstract] [Full Text] [Related]

  • 16. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
    Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR.
    Leukemia; 1995 Dec 15; 9(12):1985-9. PubMed ID: 8609706
    [Abstract] [Full Text] [Related]

  • 17. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia.
    Sacchi N, Schiaffonati L, Magnani I, Pappalardo C, Hughes AJ, Darfler M, Hoogeveen AT.
    Oncogene; 1996 Jan 18; 12(2):437-44. PubMed ID: 8570222
    [Abstract] [Full Text] [Related]

  • 18. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K, Sakota E, Kozu T.
    Biochimie; 2004 Jan 18; 86(9-10):713-21. PubMed ID: 15556282
    [Abstract] [Full Text] [Related]

  • 19. Analysis of TEL proteins in human leukemias.
    Poirel H, Lacronique V, Mauchauffé M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA.
    Oncogene; 1998 Jun 04; 16(22):2895-903. PubMed ID: 9671410
    [Abstract] [Full Text] [Related]

  • 20. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M, Stock M, Berg T, Lübbert M.
    Oncogene; 2004 Dec 02; 23(56):9070-81. PubMed ID: 15489901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 108.